Skip to main content
IC
Novo Nordisk A/S (CPH:NOVO.B)
Denmark flag Denmark · Delayed Price · Currency is DKK
441.40
-2.90 (-0.65%)
May 12, 2025, 4:59 PM CET

Novo Nordisk Revenue

Novo Nordisk had revenue of 78.09B DKK in the quarter ending March 31, 2025, with 19.49% growth. This brings the company's revenue in the last twelve months to 303.14B, up 24.11% year-over-year. In the year 2024, Novo Nordisk had annual revenue of 290.40B with 25.03% growth.

Revenue (ttm)
303.14B
Revenue Growth
+24.11%
P/S Ratio
6.46
Revenue / Employee
3.92M
Employees
77,349
Market Cap
1,959.40B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024290.40B58.14B25.03%
Dec 31, 2023232.26B55.31B31.26%
Dec 31, 2022176.95B36.15B25.68%
Dec 31, 2021140.80B13.85B10.91%
Dec 31, 2020126.95B4.93B4.04%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Coloplast 27.79B
Genmab 21.64B
Demant 22.42B
ALK-Abelló 5.71B
Zealand Pharma 55.69M
H. Lundbeck 22.00B
Ambu A/S 5.83B
GN Store Nord 17.67B
Revenue Rankings

Novo Nordisk News

More News